
Quick Sex Fix
for Quick Finishers
By PAUL H. B. SHIN
DAILY NEWS STAFF WRITER
Published: June 9, 2005
Move over, Viagra. The little blue
pill that made erectile dysfunction a household word may soon
be eclipsed by the first-ever pill to treat premature ejaculation.
Premature ejaculation afflicts more than
twice as many men as erectile dysfunction. Results of clinical
trials unveiled last month showed dapoxetine, made by New
Jersey-based Johnson & Johnson, helped men increase their
intercourse time from an average of 55 seconds to more than
three minutes.
"I see a lot of patients referred
to me for erectile dysfunction, but a lot of them turn out
to have more of a problem with premature ejaculation," said
Dr. Ivan Grunberger, vice chairman of urology at Long Island
College Hospital.
Dapoxetine is expected to receive approval
from the U.S. Food and Drug Administration early next year.
"A lot of men are living lives of
quiet desperation and really suffer," said Ian Kerner, a Manhattan
sex therapist. "The treatments out there to treat premature
ejaculation have largely been behavioral therapies, which
help, but are not entirely effective."
Dapoxetine has the same active ingredients
of some anti-depressants, like Zoloft, which have been used
in low doses for the ailment, Grunberger said.
Drug makers are also racing to produce
sex-enhancing drugs for women, for whom the most common complaint
is waning libido, especially after menopause.
"They just don't understand because
they love their husband or their boyfriend, but they don't
have any desire whatsoever," said Dr. Jacques Moritz, director
of gynecology at St. Luke's-Roosevelt Hospital in Manhattan.
"It's very distressing."
Moritz has been prescribing custom-made
creams that contain the hormone testosterone, which is responsible
for sex drive in men and women.
The FDA, which rejected approval of a testosterone
patch made for women by Proctor & Gamble in its initial
review, may find itself under growing pressure to pave the
way for a mass-market product.
"Women will force them to approve
something like that," Moritz said.
|